IMCR
Immunocore Holdings Plc
NASDAQ · Healthcare · Biotechnology · GB
$32.00
−0.93%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.16
- Revenue estimate
- $152.6M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$0.01
- Revenue actual
- $115.9M
- Revenue estimate
- $148.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +20.3%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.01 | -$0.02 | Miss -100.00% | $115.9M |
| May 6, 2026 | -$0.26 | $0.25 | Beat 196.15% | $144.8M |
| Feb 25, 2026 | -$0.28 | -$0.62 | Miss -120.06% | $104.5M |
| Nov 6, 2025 | -$0.30 | $0.02 | Beat 105.19% | $103.7M |
| Aug 7, 2025 | -$0.21 | -$0.20 | Beat 4.76% | $134.3M |
| May 7, 2025 | -$0.35 | $0.10 | Beat 128.57% | $121.5M |
| Feb 26, 2025 | -$0.31 | -$0.47 | Miss -51.61% | $105.2M |
| Aug 8, 2024 | -$0.45 | -$0.23 | Beat 48.89% | $95.4M |
| Feb 28, 2024 | -$0.28 | -$0.40 | Miss -42.86% | $133.5M |
| Aug 10, 2023 | -$0.40 | -$0.37 | Beat 7.50% | $76.6M |
| Mar 1, 2023 | -$0.00 | -$0.63 | Miss -185194.12% | $59.1M |
| Nov 9, 2022 | -$0.26 | $0.14 | Beat 153.85% | $45.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026